The Blood Group Typing market size was USD 2.26 billion in 2023 and is expected to reach USD 4.82 billion by 2032 and grow at a CAGR of 8.80% over the forecast period of 2024-2032. The report provides in-depth insights into market trends, key drivers, restraints, and opportunities shaping the industry. It highlights the rising demand for blood transfusions, the increasing prevalence of chronic diseases, and advancements in automated blood typing technologies. The report also examines regulatory frameworks, the growing adoption of molecular blood typing methods, and trends in blood donation rates globally. Detailed segment analysis by product, test type, technique, and end-user is included. Additionally, regional dominance, competitive landscape, and key developments by major players are covered. The report offers statistical insights, including blood bank inventories, transfusion rates, and disease screening trends, to provide a holistic market overview.
Get More Information on Blood Group Typing Market - Request Sample Report
The U.S. dominated the Blood Group Typing Market in North America with a market size of USD 0.768 million, holding a significant 74% market share in 2023. This dominance is driven by the high demand for blood transfusions, a well-established healthcare infrastructure, and the presence of leading diagnostic companies. The country has a high rate of voluntary blood donations, supported by organizations like the American Red Cross and AABB. Additionally, the adoption of advanced molecular blood typing techniques, including PCR-based and microarray methods, has accelerated market growth. The rising prevalence of chronic diseases, such as cancer and blood disorder, further fuels the need for accurate blood typing. Government initiatives to improve blood safety regulations and investments in automated testing technologies continue to strengthen the U.S. position as the market leader.
Drivers
The growing demand for blood transfusion and organ transplantation drives the blood group typing market growth.
The increasing demand for blood transfusions and organ transplantation procedures is a major driver of the Blood Group Typing Market. With the rising prevalence of chronic diseases, trauma cases, and complex surgeries, the need for accurate blood group identification has grown significantly. According to the World Health Organization (WHO), over 118 million blood donations occur globally each year, emphasizing the need for reliable typing methods. Additionally, advancements in automated and molecular blood typing techniques, such as gel column agglutination and PCR-based testing, enhance accuracy and efficiency. Government initiatives promoting safe blood donation practices and expanding healthcare infrastructure further support market growth. The integration of AI-driven diagnostic tools and automated blood typing analyzers by key players is also expected to improve efficiency, accuracy, and accessibility in blood group typing.
Restrain
High cost of automated blood group typing technologies hampers market growth.
The high cost associated with automated blood group typing systems and molecular diagnostic techniques poses a significant restraint in market expansion. Traditional serological blood typing methods are cost-effective and widely used, whereas automated analyzers and genetic-based blood typing solutions require high capital investment and skilled personnel. Small and mid-sized blood banks and healthcare facilities, especially in developing regions, struggle to afford advanced diagnostic equipment, limiting adoption. Furthermore, regular maintenance and reagent costs add to the financial burden, making it challenging for resource-constrained settings to implement automated solutions. Despite technological advancements, accessibility remains an issue due to limited reimbursement policies in several countries, restricting the widespread adoption of expensive blood typing methods. Addressing cost barriers through government funding and affordable diagnostic solutions could help overcome this restraint.
Opportunity
Rising demand for molecular blood typing and DNA-based testing creates growth opportunities.
The growing adoption of molecular blood typing and DNA-based blood testing presents a significant opportunity in the Blood Group Typing Market. Unlike traditional serological methods, molecular blood typing provides greater accuracy and is particularly useful for complex cases such as rare blood types, prenatal screening, and blood disorders like sickle cell disease. Companies like Bio-Rad Laboratories and Grifols are actively developing highly sensitive DNA-based assays to improve blood compatibility testing. Additionally, the integration of next-generation sequencing (NGS) and polymerase chain reaction (PCR) techniques allows for precise blood antigen detection, reducing transfusion-related risks. Governments and healthcare organizations are investing in advanced diagnostic research to enhance transfusion safety. With increasing awareness and technological advancements, molecular blood typing is expected to revolutionize the market and drive long-term growth.
Challenge
Challenges in ensuring blood safety and minimizing transfusion-related infections in blood group typing.
Despite advancements in blood typing technology, ensuring blood safety and minimizing transfusion-related infections remains a critical challenge. The risk of mismatched transfusions, alloimmunization, and transfusion-transmitted infections (TTIs), such as HIV, Hepatitis B, and Hepatitis C, continues to pose a threat to patient safety. Inaccurate blood group identification due to manual errors, reagent variability, or inadequate screening procedures can lead to serious complications. Regulatory bodies, such as the FDA and WHO, emphasize the importance of stringent blood screening protocols and the adoption of nucleic acid testing (NAT) for enhanced detection. However, many regions, especially in low-income countries, lack proper screening infrastructure, leading to inconsistent blood safety standards. Addressing this challenge requires global standardization of testing procedures, regulatory reforms, and enhanced technological adoption to ensure safe and efficient blood transfusions.
By Product
The largest revenue share 48% for the blood group typing market, was held by the Consumables segment (reagents, antisera, and test kits), supported by the increasing demand for rapid and accurate blood typing solutions. Biological ensures the accuracy and reliability of blood typing reagents and gel-based testing in advanced testing systems with the new wet blood typing reagents and gel-based testing kits for laboratories like BioRad Laboratories and Grifols. The rising volume of blood donations, transfusions, and organ transplants is another prominent factor accelerating the demand for affordable and easy-to-use consumables. The consumables segment is expected to continue to dominate with the introduction of new products and regulatory approvals. Furthermore, automation-driven AI consumable-based blood testing solutions that are being increasingly integrated by the key players are contributing to achieving high precision while testing blood hence further reinforcing its role in blood safety and compatibility on a global level.
By Technique
Assay-based techniques held the largest market share at 28% in 2023. It is owing to its high specificity, efficiency, and scalability in blood typing. Microplate-based and gel column agglutination assays for high throughput blood typing have been introduced into the market by companies such as Ortho Clinical Diagnostics and Immucor. These ideas are commonly done through blood banks and medical centers correct antigen-antibody reactions for guaranteed transfusion and blood. This segment has further benefitted from the increasing demand for automated assay systems, such as the Grifols DG Gel System. With the need for rapid and accurate blood typing methods among healthcare facilities, the ever-growing focus on standardization and scalability of testing solutions is expected to enable the adoption of assay-based techniques, as these are affordable, possess the ability to process a larger number of samples, and reduce the margins of error.
By Test Type
The ABO Blood Tests segment is projected to capture 28% of the market. ABO blood grouping is key for transfusions, organ transplants, and prenatal diagnostics. Quotient Limited, Ideally, automated abo blood type analyzers, are major players and Bio-Rad laboratories have developed automated ABO blood typing analyzer and are expected to follow traditional methods of blood testing, offering improved accuracy and efficiency. The rising demand for rapid and efficient blood group testing, particularly during emergencies and mass screening programs, is encouraging the adoption of these devices. Also, introduction of AI based blood typing analyzers and molecular based ABO testing are improving accuracy and minimizing human errors. As demand for safe blood transfusion practices is increasing all over the world, diagnosis laboratories have remained one of the main fronts for ABO blood tests, thus creating a significant shareholder in the blood group typing market.
The North America dominated blood group typing market with a share of 46% in 2023, higher blood donation rates, advanced healthcare infrastructure, and a rising number of organ transplants are a few factors driving the growth of the market in the region. Each year, nearly 6.8 million people donate blood (U.S. Red Cross), driving the need for solutions to automate and perform blood typing accurately. However, there are automated blood typing analyzers developed by companies such as Ortho Clinical Diagnostics and Immucor that have brought in increased efficiency to be used in hospitals and blood banks. Moreover, stringent regulatory bodies (such as FDA) in this region provide standard, secure blood testing procedures, which is likely to contribute to market growth in North America. North America is expected to show high growth rate in the blood typing systems and molecular based techniques due to the rapidly opening AI powered blood typing systems with the molecular-based techniques applications this move at a fast pace to ensure the blood safety and compatibility testing.
Asia Pacific held the significant market share. As blood transfusions are required for an increasing number of surgeries, trauma cases, and chronic diseases, the growth of the total blood transfusions market is also on the rise. Nations like China and India see a climb within the numbers of voluntary blood donations as government support and campaigns on awareness maintain to protect among the populations. As an example, National Blood Transfusion Council of India is spearheading a push to promote 100% voluntary blood donation, thus, raising the demand for swift blood typing solutions. Moreover, the companies such as Bio-Rad and Grifols are also expanding their automated blood typing systems in hospitals and diagnostic lab thereby propelling the market growth. In addition, the region is dominating the technology segment due to increased acceptance of molecular blood typing and next-generation sequencing.
Get Customized Report as per Your Business Requirement - Request For Customized Report
Grifols S.A. (Erytra Eflexis, DG Gel Cards)
Merck KGaA (Millipore Blood Typing Reagents, Simplicon RNA Reagents)
Bio-Rad Laboratories, Inc. (IH-500 System, ID-MTS Gel Cards)
Immucor Inc. (Echo Lumena, PreciseType HEA Test)
Novacyt Group (Genesig Real-Time PCR, SNPsig Assays)
Danaher Corporation (Beckman Coulter PK7300, PK7400)
Agena Bioscience, Inc (MassARRAY System, iPLEX Pro Reagents)
Ortho Clinical Diagnostics (ORTHO VISION Analyzer, ORTHO BioVue System)
Quotient Ltd. (MosaiQ Platform, Alba Reagents)
QuidelOrtho (Quidel Triage, Sofia2 Analyzer)
Thermo Fisher Scientific (TaqPath Blood Typing Kit, Applied Biosystems 7500)
Siemens Healthineers (ADVIA Centaur, Atellica IM)
Roche Diagnostics (Cobas 8000, Elecsys Anti-D)
Abbott Laboratories (Alinity s System, ARCHITECT i1000SR)
Beckman Coulter (UniCel DxH 800, DxH 900)
Becton Dickinson (BD Vacutainer, BD Veritor)
Sysmex Corporation (XN-Series Hematology Analyzers, UF-Series Urine Analyzers)
BioMérieux (Vitek 2, BACT/ALERT 3D)
MedGenome (SeqType Blood Typing, OncoMD)
Luminex Corporation (xMAP Technology, ARIES System)
In May 2023, Bio-Rad Laboratories, Inc. introduced the IH-500™ NEXT System, a fully automated platform aimed at minimizing instrument downtime and enhancing laboratory efficiency. This advanced system provides greater flexibility by supporting the use of both Bio-Rad's Reagent Red Blood Cells (RBCs) and third-party RBCs.
In May 2024, Thermo Fisher Scientific introduced the Applied Biosystems Axiom BloodGenomiX Array and Software, a pioneering solution aimed at enhancing blood genotyping precision in clinical research. This array is capable of detecting over 40 genes and 260 antigens across 38 blood group systems, including tissue (HLA) and platelet (HPA) types, within a single, high-throughput assay.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD2.26 Billion |
| Market Size by 2032 | USD 4.82 Billion |
| CAGR | CAGR of8.80 % From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Consumables, Instruments, Services), • By Technique (PCR-based and Microarray Techniques, Assay-based Techniques, Massively Parallel Sequencing Techniques, Others), • By Test Type (Antibody Screening, HLA Typing, Cross-matching Tests, ABO Blood Tests, Antigen Typing), |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | LyondellBasell Industries, W. R. Grace & Co., Clariant AG, China Petrochemical Corporation, Mitsui Chemicals, Inc., BASF SE, Evonik Industries AG, Univation Technologies, LLC, Sumitomo Chemical Co., Ltd., INEOS Group Holdings S.A., ExxonMobil Chemical, Japan Polypropylene Corporation, Reliance Industries Limited, Borealis AG, Wacker Chemie AG, Albemarle Corporation, UOP LLC, Shell Chemicals, SABIC, Axens SA |
Ans: The Blood Group Typing Market was valued at USD 2.26 Billion in 2023.
Ans: The expected CAGR of the global Blood Group Typing Market during the forecast period is 8.80%
Ans: Consumables Products will grow rapidly in the Blood Group Typing Market from 2024-2032.
Ans: The growing demand for blood transfusion and organ transplantation drives the blood group typing market growth
Ans: North America led the Blood Group Typing Market in the region with the highest revenue share in 2023.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Blood Donation and Transfusion Rates
5.2 Automation and Technological Penetration
5.3 Growth in Demand for Pre-Natal Blood Typing.
5.4 Regulatory Compliance Statistics
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Blood Group Typing Market Segmentation by Product
7.1 Chapter Overview
7.2 Consumables
7.2.1 Consumables Market Trends Analysis (2020-2032)
7.2.2 Consumables Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Instruments
7.3.1 Instruments Market Trends Analysis (2020-2032)
7.3.2 Instruments Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Services
7.4.1 Services Market Trends Analysis (2020-2032)
7.4.2 Services Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Blood Group Typing Market Segmentation By Technique
8.1 Chapter Overview
8.2 PCR-based and Microarray Techniques
8.2.1 PCR-based and Microarray Techniques Market Trend Analysis (2020-2032)
8.2.2 PCR-based and Microarray Techniques Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Assay-based Techniques
8.3.1 Assay-based Techniques Market Trends Analysis (2020-2032)
8.3.2 Assay-based Techniques Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Massively Parallel Sequencing Techniques
8.4.1 Massively Parallel Sequencing Techniques Market Trend Analysis (2020-2032)
8.4.2 Massively Parallel Sequencing Techniques Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Blood Group Typing Market Segmentation By Test Type
9.1 Chapter Overview
9.2 Antibody Screening
9.2.1 Antibody Screening Market Trends Analysis (2020-2032)
9.2.2 Antibody Screening Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 HLA Typing
9.3.1 HLA Typing Market Trends Analysis (2020-2032)
9.3.2 HLA Typing Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Cross-matching Tests
9.4.1 Cross-matching Tests Market Trends Analysis (2020-2032)
9.4.2 Cross-matching Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 ABO Blood Tests
9.5.1 ABO Blood Tests Market Trends Analysis (2020-2032)
9.5.2 ABO Blood Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
9.6 Antigen Typing
9.5.1 Antigen Typing Market Trends Analysis (2020-2032)
9.5.2 Antigen Typing Market Size Estimates and Forecasts to 2032 (USD Billion
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Blood Group Typing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.4 North America Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.2.5 North America Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.6.2 USA Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.2.6.3 USA Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.7.2 Canada Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.2.7.3 Canada Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.8.2 Mexico Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.2.8.3 Mexico Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Blood Group Typing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.1.6.3 Poland Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.1.7.3 Romania Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Blood Group Typing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.2.5 Western Europe Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.2.6.3 Germany Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.7.2 France Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.2.7.3 France Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.8.2 UK Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.2.8.3 UK Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.2.9.3 Italy Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.2.10.3 Spain Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.2.13.3 Austria Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Blood Group Typing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.4.5 Asia Pacific Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.6.2 China Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.4.6.3 China Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.7.2 India Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.4.7.3 India Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.8.2 Japan Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.4.8.3 Japan Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.9.2 South Korea Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.4.9.3 South Korea Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.4.10.3 Vietnam Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.11.2 Singapore Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.4.11.3 Singapore Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.12.2 Australia Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.4.12.3 Australia Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Blood Group Typing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.4 Middle East Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.5.1.5 Middle East Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.5.1.6.3 UAE Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Blood Group Typing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.4 Africa Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.5.2.5 Africa Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Blood Group Typing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.4 Latin America Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.6.5 Latin America Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.6.2 Brazil Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.6.6.3 Brazil Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.7.2 Argentina Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.6.7.3 Argentina Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.8.2 Colombia Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.6.8.3 Colombia Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Blood Group Typing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Blood Group Typing Market Estimates and Forecasts, By Technique (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Blood Group Typing Market Estimates and Forecasts, By Test Type (2020-2032) (USD Billion)
11. Company Profiles
11.1 Grifols
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Product/ Services Offered
11.1.4 SWOT Analysis
11.2 Merck KGaA
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Product/ Services Offered
11.2.4 SWOT Analysis
11.3 Bio-Rad Laboratories Inc.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Product/ Services Offered
11.3.4 SWOT Analysis
11.4 Immucor, Inc.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Product/ Services Offered
11.4.4 SWOT Analysis
11.5 Novacyt Group
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Product/ Services Offered
11.5.4 SWOT Analysis
11.6 Danaher Corporation
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Product/ Services Offered
11.6.4 SWOT Analysis
11.7 Agena Bioscience, Inc
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Product/ Services Offered
11.7.4 SWOT Analysis
11.8 Ortho Clinical Diagnostics,
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Product/ Services Offered
11.8.4 SWOT Analysis
11.9 Quotient. Ltd
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.10 Bio-Rad Laboratories, Inc
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Product/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Product
Consumables
Instruments
Services
By Technique
PCR-based and Microarray Techniques
Assay-based Techniques
Massively Parallel Sequencing Techniques
Others
By Test Type
Antibody Screening
HLA Typing
Cross-matching Tests
ABO Blood Tests
Antigen Typing
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Urgent Care Apps Market Size was valued at USD 2230.17 million in 2023 and is expected to reach USD 31983.94 million by 2031 and grow at a CAGR of 39.5% over the forecast period 2024-2031.
Artificial Intelligence (AI) in Diagnostics Market Size was valued at USD 1.25 Billion in 2023 and is expected to reach USD 7.75 Billion by 2032, growing at a CAGR of 22.5% over the forecast period 2024-2032.
The Molecular Biology Enzymes, Reagents, and Kits Market was valued at USD 23.01 billion in 2023 and is expected to reach USD 52.78 billion by 2032, growing at a CAGR of 9.68% over the forecast period of 2024-2032.
The Epilepsy Device Market Size was valued at USD 0.75 billion in 2023 and is expected to reach USD 1.18 billion by 2032 and grow at a CAGR of 5.15% over the forecast period 2024-2032.
The Chemiluminescence Immunoassay Market Size was valued at USD 11.76 Billion in 2023 and is expected to reach USD 17.72 Billion by 2032 and grow at a CAGR of 4.68% over the forecast period 2024-2032.
The Single-use Bioprocessing Market size was USD 26.8 billion in 2023 and is expected to reach USD 100.9 billion by 2032 at a CAGR of 15.9%.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
